Stockscreener 앱 받기
12.72
4.69%
0.57
시간 외 거래:
12.73
0.010
+0.08%
전일 마감가:
$12.15
열려 있는:
$12.16
하루 거래량:
170.11K
Relative Volume:
3.54
시가총액:
$337.29M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-6.47%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$12.15
$12.78
1주일 범위
$11.81
$13.90
52주 변동 폭
$11.81
$15.10
Carlsmed Inc Stock (CARL) Company Profile
CARL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
12.72 | 321.11M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
282.13 | 46.19B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
60.87 | 9.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.58 | 10.89B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.05 | 7.86B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.59 | 5.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
Carlsmed Inc 주식(CARL)의 최신 뉴스
Heartflow raises $317M, pops 66% at market open - BioWorld MedTech
Carlsmed’s $100.5M IPO fuels 3D printed spinal implants growth - 3D Printing Industry
Carlsmed’s aprevo implants receive CMS NTAP for cervical fusion procedures - TipRanks
Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - Ortho Spine News
Carlsmed's Aprevo Implants Receive CMS NTAP Approval For Cervical Fusion Procedures Under FY2026 IPPS Final Rule - 富途牛牛
Carlsmed's Aprevo Personalized Interbody Implants Receive CMS NTAP for Cervical Fusion Procedures - AInvest
AI medtech firm Carlsmed prices $100.5M IPO - MSN
US Life Sciences IPOs Revive with Medtech Companies Leading the Way - AInvest
Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - Bloomberg.com
Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery - MarketScreener
Carlsmed announces completion of first aprevo cervical procedure - TipRanks
Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery - Ortho Spine News
Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery. - AInvest
Carlsmed’s Nasdaq Debut Gets $100.5M - San Diego Business Journal
Carlsmed Launches $100.5 Million Initial Public Offering - Global Legal Chronicle
Carlsbad-based medical technology company begins trading on Nasdaq - MSN
Latham & Watkins Advises on Carlsmed, Inc.’s US$100.5 Million Initial Public Offering - Latham & Watkins LLP
Carlsmed Insider Bought Shares Worth $899,985, According to a Recent SEC Filing - MarketScreener
Carlsmed director Mittendorff buys $20 million in shares By Investing.com - Investing.com UK
Carlsmed director Philip Young buys $900k in shares By Investing.com - Investing.com Canada
Carlsmed (CARL) director Sidow buys $199,995 in shares By Investing.com - Investing.com India
Carlsmed (CARL) director Sidow buys $199,995 in shares - Investing.com Australia
Carlsmed director Philip Young buys $900k in shares - Investing.com
Carlsmed director Mittendorff buys $20 million in shares - Investing.com
Carlsmed, Inc. Completes Initial Public Offering - TipRanks
Carlsmed 6.7M share IPO priced at $15 per share - MSN
Carlsmed: Redefining Precision And Personalization In Spine Surgery With AI-Powered Aprevo - RTTNews
Carlsmed, Inc.(NasdaqGS: CARL) added to NASDAQ Composite Index - MarketScreener
Carlsmed: Spine Play Does Not Have My Backing Yet (NASDAQ:CARL) - Seeking Alpha
Carlsmed times IPO with reimbursement boon - Axios
Carlsmed Inc. (CARL): MedTech Makes Uninspiring Debut, Opens Flat and Trades Below Issue - Smartkarma
AI Spine Surgery Firm Carlsmed Shares Fall 3.3% After IPO - Bloomberg
Carlsmed begins trading on Nasdaq at $15 per share - Investing.com
Carlsmed (CARL): Assessing the Post-IPO Dip in a High-Growth MedTech Disruptor - AInvest
Carlsmed begins trading on Nasdaq at $15 per share By Investing.com - Investing.com Canada
Carlsmed, Inc Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Carlsmed, Inc Rings the Opening Bell - Nasdaq
Carlsmed Prices $100.5 Million IPO - MarketScreener
Carlsmed raises USD 100.5M through IPO - Medical Buyer
Carlsmed Inc (CARL) 재무 분석
Carlsmed Inc (CARL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.97%
6.08%
자본화:
|
볼륨(24시간):